This company listing is no longer active
Amryt Pharma Dirección
Dirección controles de criterios 2/4
Información clave
Joe Wiley
Chief Executive Officer (CEO)
US$1.7m
Compensación total
Porcentaje del salario del CEO | 43.4% |
Permanencia del CEO | 8.3yrs |
Participación del CEO | 1.1% |
Permanencia media de la dirección | 3.3yrs |
Promedio de permanencia en la Junta Directiva | 3.6yrs |
Actualizaciones recientes de la dirección
Recent updates
Análisis de compensación del CEO
Fecha | Compensación total | Salario | Ingresos de la empresa |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$790k |
Jun 30 2022 | n/a | n/a | US$3m |
Mar 31 2022 | n/a | n/a | US$3m |
Dec 31 2021 | US$2m | US$747k | US$1m |
Sep 30 2021 | n/a | n/a | -US$88m |
Jun 30 2021 | n/a | n/a | -US$81m |
Mar 31 2021 | n/a | n/a | -US$92m |
Dec 31 2020 | US$2m | US$727k | -US$105m |
Sep 30 2020 | n/a | n/a | -US$87m |
Jun 30 2020 | n/a | n/a | -US$92m |
Mar 31 2020 | n/a | n/a | -US$87m |
Dec 31 2019 | US$1m | US$588k | -US$63m |
Compensación vs. Mercado: Joe's total compensation ($USD1.72M) is above average for companies of similar size in the German market ($USD1.29M).
Compensación vs. Ingresos: Joe's compensation has increased whilst the company is unprofitable.
CEO
Joe Wiley (51 yo)
8.3yrs
Permanencia
US$1,720,000
Compensación
Dr. Joseph A. Wiley, also known as Joe, M.D. was the Founder of Amryt Pharma plc and serves as its Chief Executive Officer since 2015. He has been a Director at Amryt Pharma plc since April 19, 2016. Dr. W...
Equipo directivo
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Director | 8.3yrs | US$1.72m | 1.1% $ 9.4m | |
CFO, COO & Company Secretary | 8.3yrs | US$939.00k | 0.51% $ 4.4m | |
Chief Compliance Officer | 2.3yrs | sin datos | sin datos | |
General Counsel | 5.6yrs | sin datos | sin datos | |
Head of Marketing & Head of APAC | 4.3yrs | sin datos | sin datos | |
Head of Human Resources | no data | sin datos | sin datos | |
Head of Medical Affairs | no data | sin datos | sin datos | |
President of Americas | 2yrs | sin datos | sin datos | |
Chief Medical Officer | less than a year | sin datos | sin datos | |
President of EMEA Region | less than a year | sin datos | sin datos |
3.3yrs
Permanencia media
54.5yo
Promedio de edad
Equipo directivo experimentado: 3N9A's management team is considered experienced (3.3 years average tenure).
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
CEO & Director | 7yrs | US$1.72m | 1.1% $ 9.4m | |
Independent Non-Executive Director | 3.6yrs | US$88.00k | 0.023% $ 199.6k | |
Independent Non-Executive Director | 3.6yrs | US$58.00k | 0.0070% $ 59.9k | |
Independent Non-Executive Director | 3.6yrs | US$60.00k | 0.0078% $ 66.5k | |
Independent Non-Executive Director | 3.6yrs | US$80.00k | 0% $ 0 | |
Independent Non-Executive Chairman of the Board | 7yrs | US$88.00k | 0.61% $ 5.2m | |
Independent Non-Executive Director | 1.7yrs | US$20.00k | 0% $ 0 | |
Independent Non-Executive Director | 3.6yrs | US$65.00k | 0.031% $ 266.1k | |
Independent Non-Executive Director | 1.7yrs | US$20.00k | 0% $ 0 |
3.6yrs
Permanencia media
59yo
Promedio de edad
Junta con experiencia: 3N9A's board of directors are considered experienced (3.6 years average tenure).